Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,779,248
+$147,932 QoQ
Shares Held
18,721
-0.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#696
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. AMGN ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
This page
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,779,248 | 18,721 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,631,316 | 18,847 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,183,540 | 18,892 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,452,104 | 19,320 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,445,711 | 19,504 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,145,012 | 19,724 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,292,295 | 20,305 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,577,917 | 20,415 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,477,713 | 20,732 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,986,073 | 21,054 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,163,051 | 21,398 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,797,153 | 21,570 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,803,846 | 21,637 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,262,414 | 21,768 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,756,280 | 21,917 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,175,634 | 22,962 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,596,386 | 23,002 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,691,959 | 23,538 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,353,161 | 23,795 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,154,210 | 24,238 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,038,662 | 24,774 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,362,320 | 25,571 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,904,345 | 25,680 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,537,757 | 25,723 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,234,251 | 26,432 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,727,325 | 28,251 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||